ARTICLE | Company News
ChromaVision, NewBiotics deal
November 11, 2002 8:00 AM UTC
CVSN will use its ACIS digital imaging system to analyze tissue samples from colon cancer patients in NewBiotics’ Phase I and II trials of Thymectacin. CVSN will receive a fee per specimen. ...